Targeting FZD6 creates therapeutically actionable vulnerabilities for advanced prostate cancer. Li Y, Zhou Z, Zhang Y, Jia D, et al. Oncogene 2025 Nov 24. doi: 10.1038/s41388-025-03631.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li Y, Zhou Z, Zhang Y, Jia D, et al. Targeting FZD6 creates therapeutically actionable vulnerabilities for advanced prostate cancer. Oncogene 2025 Nov 24. doi: 10.1038/s41388-025-03631.
PMID: 41286306